Skip to main content
. 2014 Nov 26;13:253. doi: 10.1186/1476-4598-13-253

Figure 6.

Figure 6

MiR-149 inhibits cell proliferation, invasion and migration of HCC cells in vitro by targeting AKT1/mTOR pathway. (A and B) Western blot analysis of AKT1, p-AKT1, mTOR and mTOR protein expression levels in HepG2 cells transfected with RNAi-AKT1 or RNAi-control vectors. (C-E) Overexpression of miR-149 fails to inhibit proliferation, invasion, and migration in AKT1 knockdown HepG2 cells.